BAZ1A and malignant colon neoplasm: Notably, almost 100% of colorectal cancer patients had BAZ1A detectable in tumor samples (Fig. 1A, red bar), with high BAZ1A immunopositivity in colon cancer tissue microarrays compared with normal colon samples (Fig. 1B).